Top 15 Medical Angel Investors in Australia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Kurt Alexander
Angel
|
2 | Australia | Seed | Mining, Retail, Medical | |
|
Li Ka-shing
Angel
|
1 | United States, United Kingdom, Israel | Series A, Series B, Seed | Health Care, Biotechnology, Food and Beverage | $300k–$50M |
|
Donald Kirk
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
Luke & Janelle Roberts
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
William Welty
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
Artesian Investment
Angel
|
1 | United States, India, Australia | Pre-Seed, Seed, Series A | Artificial Intelligence, Agriculture, Information Technology | |
|
Anton Borzov
Angel
|
1 | United States, Estonia, Ukraine | Seed, Pre-Seed, Series A | Information Technology, Artificial Intelligence, Medical | $500k–$2.6M |
|
Orrin Benford
Angel
|
1 | Australia | Seed | Medical, Child Care, Health Care | |
|
Carl Stubbings
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Richard Lipscombe
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Stephen Ho
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Jutech Pty Ltd
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
Catherine Lacavera
Angel
|
1 | Canada, Australia | Seed, Pre-Seed | Medical, Health Care, Biotechnology | |
|
Stephen Baxter
Angel
|
1 | Australia | Seed, Angel, Series B | Software, Transportation, IaaS | $500k–$2.6M |
|
Andrew R Banks
Angel
|
1 | Australia | Seed | Grocery, Medical, Health Care | $300k–$950k |
| Access all 22 angel investors in Australia Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Kurt Alexander
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes). His primary operating company is Hutchison Whampoa Limited. Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 25
- Round size: Seed $300k–$11M; Series A $21M–$50M; Series B $15M–$50M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- H2Pro — H2Pro is a renewable energy company that is working on an efficient green hydrogen production method - E-TAC. Its mission is to enable the wide-scale adoption of sustainable hydrogen fuel by introducing a novel water-splitting technology.
- Omni — Omni aims to revolutionise mobility in cities and campuses by empowering residents with cleaner, more efficient, and affordable transportation options that improve urban sustainability in the United Kingdom. By systematically deploying thousands of smart-bikes, enabled with GPS, wireless technology, and self-locks, we will dramatically improveurban mobility by making the first and last mile faster, cheaper, and healthier. We take city and school friendly approach and seek for partnership to work on this challenging problem.
- Fertilis — Fertilis: A better way to care for your embryos in an IVF clinic. Fertilis technology involves each embryo growing inside its own patented micro-3D printed pod. The pod protects the embryo and enables automated subtle changes to the nutritive composition of the solutions that bathe the embryo.
Donald Kirk
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Luke & Janelle Roberts
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
William Welty
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Artesian Investment
Show more...Investment focus
- Industry: Artificial Intelligence, Agriculture, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, India, Australia
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
- LYRO Robotics — A robotic packing solution for fruits and vegetables
- HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Anton Borzov is the Product Designer at Neeva.
Show more...Investment focus
- Industry: Information Technology, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Estonia, Ukraine
Investor stats
- Total investments: 7
- Round size: Seed $500k–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Liki24 — Liki24 is a logistics company that features a software platform that utilizes deep integration with partner pharmacies, clinics, and insurance companies. Its software is designed for logistics team coordination, task management, and data management.
- Cargofy — Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high paying loads through our app, and receive discounts on fuel, maintenance, and truck parts.
- Puma Browser — Puma is a mobile browser and wallet for the Web3 ecosystem. Private by design. Today, we enable seamless payments for creators, app & game developers via Coil and ILP protocol and access to HNS & ENS domains. Long term, our goal is to give 1b people access to Web3 world, DeFi, the peer to peer and ownership based economy.
Orrin Benford is a COO at LVL Wellbeing. He Attended The Chartered Institute of Management Accountants.
Show more...Investment focus
- Industry: Medical, Child Care, Health Care
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
Carl Stubbings is the Chief Commercial Officer at Genetic Technologies Limited.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research).
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Stephen Ho
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Jutech Pty Ltd
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Canada, Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
Stephen Baxter - Founder @ River City Labs
Show more...Investment focus
- Industry: Software, Transportation, IaaS
- Stage:Seed, Angel, Series B
- Geography: Australia
Investor stats
- Total investments: 8
- Round size: Seed $500k–$2.6M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Travelshoot — Your holidays are really important to us to create good memories and we are offering Worldwide Photographer Services. Get the best vacation photographer NYC & across the globe. Visit us now!
- Car Next Door — Hire a car, van or ute from our community of local car owners, or rent out your car and make extra money. Peer-to-peer car share in Sydney, Melbourne, Newcastle.
Andrew R Banks
Show more...Investment focus
- Industry: Grocery, Medical, Health Care
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Seed $300k–$950k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
- Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Medical Angel investor funding in Australia at a glance
Stats across 12 deals from 22 investors.
Access all 22 angel investors in Australia Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 22 angel investors investing in Australia Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
